On April 2, 2026, Inovio Pharmaceuticals, Inc. announced a public offering of 12,500,000 shares and related warrants at $1.40 each, expecting to raise about $16 million after expenses. An additional option for underwriters to purchase 1,875,000 more shares is available within 30 days.